Back to MW MARSHALL WACE, LLP

RVNCRVNC
14 quarters

Position history for MWMARSHALL WACE, LLP's holdings in REVANCE THERAPEUTICS INC

MARSHALL WACE, LLP previously held 0 shares of RVNC (REVANCE THERAPEUTICS INC), worth $0 as of 2025-Q1.

Final Value

$0

Final Shares

0

Total Value Change

-$966,000

Total Shares Change

-61,350

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q1
Latest
Exited
0
-100.0%
$00.0%—
0
2024-Q4
Decreased
252,468
-55.5%
$767,5040.0%—
0
2024-Q3
New
567,300
-
$2.9M0.0%—
36
2024-Q2
Exited
0
-100.0%
$00.0%—
0
2024-Q1
New
781,223
-
$3.8M0.0%—
37
2023-Q4
Exited
0
-100.0%
$00.0%—
0
2023-Q3
Increased
713,638
+688.3%
$8.2M0.0%—
44
2023-Q2
New
90,528
-
$2.3M0.0%—
36
2022-Q4
Exited
0
-100.0%
$00.0%—
0
2022-Q3
Increased
41,253
+144.7%
$1.1M0.0%—
41
2022-Q2
Decreased
16,858
-86.3%
$233,0000.0%—
0
2022-Q1
New
122,598
-
$2.4M0.0%—
36
2019-Q2
Exited
0
-100.0%
$00.0%—
0
2019-Q1
New
61,350
-
$966,0000.0%—
35

Other major holders of RVNC: BNP PARIBAS FINANCIAL MARKETS, Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used